Adam K. Stern, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 80,000 shares at $0.94 ($75K) on 2019-05-31, disclosed to the SEC on 2019-06-03.
Open-market purchase of $75k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| MTNB | BUY | 2020-08-24 | $17K | — | Filing → |
| DRIO | BUY | 2020-07-06 | $4K | — | Filing → |
| DRIO | BUY | 2020-06-09 | $15K | — | Filing → |